Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

All Risk, No Reward

Is Aspirin Dead in A-Fib?

Neda Frayha, MD and Rob Orman, MD
00:00
12:14
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Tags Ambulatory Family Medicine · Cardiovascular CV · pharmacology

In this PC RAP family reunion, Rob Orman and Neda Frayha discuss the latest evidence on the use of aspirin in low-risk a-fib (CHA2DS2-VASc score of 0 or 1).  

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

Ian L., Dr -

Aspirin might be of low efficacy but the LEGACY trial the long term effect of weight loss in atrial fibrillation by Pathak RK et al showed a six fold reduction in "arrhythmia free survival " in patients who sustained a 10% of body weight over one year.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
All Risk, No Reward Full episode audio for MD edition 187:18 min - 88 MB - M4AHippo PC RAP July 2018 Written Summary 362 KB - PDF